Literature DB >> 22658655

Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Freddie Bray1, Ahmedin Jemal, Nathan Grey, Jacques Ferlay, David Forman.   

Abstract

BACKGROUND: Cancer is set to become a major cause of morbidity and mortality in the coming decades in every region of the world. We aimed to assess the changing patterns of cancer according to varying levels of human development.
METHODS: We used four levels (low, medium, high, and very high) of the Human Development Index (HDI), a composite indicator of life expectancy, education, and gross domestic product per head, to highlight cancer-specific patterns in 2008 (on the basis of GLOBOCAN estimates) and trends 1988-2002 (on the basis of the series in Cancer Incidence in Five Continents), and to produce future burden scenario for 2030 according to projected demographic changes alone and trends-based changes for selected cancer sites.
FINDINGS: In the highest HDI regions in 2008, cancers of the female breast, lung, colorectum, and prostate accounted for half the overall cancer burden, whereas in medium HDI regions, cancers of the oesophagus, stomach, and liver were also common, and together these seven cancers comprised 62% of the total cancer burden in medium to very high HDI areas. In low HDI regions, cervical cancer was more common than both breast cancer and liver cancer. Nine different cancers were the most commonly diagnosed in men across 184 countries, with cancers of the prostate, lung, and liver being the most common. Breast and cervical cancers were the most common in women. In medium HDI and high HDI settings, decreases in cervical and stomach cancer incidence seem to be offset by increases in the incidence of cancers of the female breast, prostate, and colorectum. If the cancer-specific and sex-specific trends estimated in this study continue, we predict an increase in the incidence of all-cancer cases from 12·7 million new cases in 2008 to 22·2 million by 2030.
INTERPRETATION: Our findings suggest that rapid societal and economic transition in many countries means that any reductions in infection-related cancers are offset by an increasing number of new cases that are more associated with reproductive, dietary, and hormonal factors. Targeted interventions can lead to a decrease in the projected increases in cancer burden through effective primary prevention strategies, alongside the implementation of vaccination, early detection, and effective treatment programmes. FUNDING: None.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22658655     DOI: 10.1016/S1470-2045(12)70211-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  561 in total

1.  Efficacy of traditional Chinese medicine in treating cancer.

Authors:  Jiao Nie; Changlin Zhao; L I Deng; Jia Chen; Bin Yu; Xianlin Wu; Peng Pang; Xiaoyin Chen
Journal:  Biomed Rep       Date:  2015-11-05

2.  Impact of a 3-Day Introductory Oncology Course on First-Year International Medical Students.

Authors:  Leeat Granek; Yuval Mizrakli; Samuel Ariad; Alan Jotkowitz; David B Geffen
Journal:  J Cancer Educ       Date:  2017-09       Impact factor: 2.037

Review 3.  Cholecystectomy and the risk of alimentary tract cancers: a systematic review.

Authors:  Maria Coats; Sami M Shimi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

4.  Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer.

Authors:  Jing Jiang; Mei-Shan Jin; Fei Kong; Yin-Ping Wang; Zhi-Fang Jia; Dong-Hui Cao; Hong-Xi Ma; Jian Suo; Xue-Yuan Cao
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

5.  An investigation of the prevalence of swallowing difficulties and impact on quality of life in patients with advanced lung cancer.

Authors:  Grainne C Brady; Justin W G Roe; Mary O' Brien; Annette Boaz; Clare Shaw
Journal:  Support Care Cancer       Date:  2017-09-02       Impact factor: 3.603

Review 6.  Phytochemicals: Current strategies for treating breast cancer.

Authors:  Bridg'ette B Israel; Syreeta L Tilghman; Kitani Parker-Lemieux; Florastina Payton-Stewart
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

Review 7.  The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Authors:  Nicolas Iragorri; Claire de Oliveira; Natalie Fitzgerald; Beverley Essue
Journal:  Curr Oncol       Date:  2021-03-15       Impact factor: 3.677

8.  Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.

Authors:  Spyridon Christodoulou; Dimitra K Alexopoulou; Christos K Kontos; Andreas Scorilas; Iordanis N Papadopoulos
Journal:  Tumour Biol       Date:  2014-01-16

9.  Relationship of serum levels of VEGF and TGF-β1 with radiosensitivity of elderly patients with unresectable non-small cell lung cancer.

Authors:  Zhan-Zhao Fu; Tao Gu; Bao-Hong Fu; Hai-Xia Hua; Sen Yang; Yan-Qiu Zhang; Li-Ming Gao; Ping Li
Journal:  Tumour Biol       Date:  2014-02-21

10.  Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells.

Authors:  Sheng Hu; Qiang Zhou; Wan-Rui Wu; Yi-Xing Duan; Zhi-Yong Gao; Yuan-Wei Li; Qiang Lu
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.